BEVERLY HILLS, Calif., Oct. 13, 2017 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, including SteraMist™, a hydrogen peroxide-based mist/fog registered with the U.S. Environmental Protection Agency (“EPA”) for use as a hospital-healthcare disinfectant, will exhibit at the 60th annual biological safety conference of ABSA, the American Biological Safety Association, in Albuquerque, New Mexico, October 13-18th. This conference offers an opportunity to learn best practices protocols in the industry and network with biosafety and biosecurity professionals from all over the world. It will also feature exhibits showcasing the latest in laboratory biosafety and biosecurity products and services, of which SteraMist™ is included.
The three-day intensive course load includes presentations on a variety of topics including facing the next pandemic, compliance and regulatory issues, international biosafety and decontamination technologies. One highlighted speaker of decontamination methods is Miguel Grimaldo, Assistant Professor for the Department of Pathology, Director of Institutional Biocontainment Resources at the University of Texas Medical Branch (UTMB) and the Director of the Biocontainment Engineering Division for the Galveston National Laboratory. His speaking topics address biocontainment in laboratory operations and facility biosafety. Specifically, in one of his panel discussions, Grimaldo will review Decontamination with Cold Plasma Activated Ionized Hydrogen Peroxide.
As the sole owner of iHP™ decontamination technology, patents, and products, TOMI markets under the brands Binary Ionization Technology® (BIT™) and SteraMist™. This powerful tool is capable of eliminating contamination challenges within critical environments faster than competing technologies and without the production of potentially harmful or damaging by-products. According to TOMI CEO, Dr. Halden Shane, “There is great synergy for us at ABSA. In a short amount of time, we have already made significant in-roads in the biosafety sector and are excited to bring greater awareness to the limitless capabilities and unmatched efficacy of this technology.”
The ABSA conference will be held at the Albuquerque Convention Center and TOMI representatives in attendance will feature product demonstrations. To learn more about the company’s full range of products and services, attendees are encouraged to visit Booth 200P.
About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.
TOMI also develops training programs and application protocols for its clients and is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release
MEDIA RELATIONS CONTACT